Search
RuiChu Robotics Formally Files for HKEX Listing, Seeks Capital for Core Product R&D and Market Rollout
1 day ago /
Read about 0 minute
Author：小编
On May 27, the Hong Kong Stock Exchange (HKEX) disclosed that RuiChu Robotics has formally submitted an application to list on the HKEX main board, with Everbright Securities International acting as the sole sponsor. RuiChu Robotics stands as a trailblazer and a dominant player in China's market for percutaneous puncture surgical robots. Its self-developed RC120 puncture surgical robot secured the Class III medical device registration certificate in 2024 and has since been deployed for clinical use in 39 hospitals nationwide. According to the trial installation data from 2024, the RC120 holds the second-highest position in China's percutaneous puncture surgical robot market.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
